Kate Therapeutics Inc. — Form D
Kate Therapeutics Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-08-07. The offering totals $35.0M, of which $35.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-08-07
- Form: D
- Accession: 0002027042-24-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $35.0M
- Amount sold: $35.0M
- Investors: 5
- Date of first sale: 2021-08-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-520820
Issuer
- Name: Kate Therapeutics Inc.
- CIK: 0002032702
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 10675 SORRENTO VALLEY ROAD, SUITE 150, SAN DIEGO, CA, 92121
- Phone: 619-614-3609
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Beth Seidenberg, M.D. | Director | SOUTH SAN FRANCISCO, CA |
| Clare Ozawa, Ph.D. | Director | San Diego, CA |
| Kevin Forrest, Ph.D. | Director | San Diego, CA |
| Kevin Forrest, Ph.D. | Executive Officer | San Diego, CA |
Other filings by this issuer (2)
More